The report states that medical cannabis makes up the biggest part of the market segment, taking up most of the revenue shares based on 2019 figures at 71%. This is attributed to the increasing adoption of cannabis as a legitimate alternative to pharmaceuticals, especially for treating life-threatening conditions including cancer, Parkinson’s disease, Alzheimer’s disease, arthritis, and neurological disorders among others. There is also a rising demand for effective painkillers as well as chronic pain medications for the elderly, and this is where much product demand is expected to be seen.
The industry’s attention still gravitates toward the legacy states. But through operators like SWADE Cannabis…
Metro Boomin and Action Bronson are headlining Puffcon in October, and that alone is worth…
Mary Jane Berlin brought tens of thousands of people into one building and reminded them…
Sacha Baron Cohen has reportedly been filming a new Ali G movie in secret. Could…
Big news for wellness enthusiasts: Canna River, the family-run brand that’s spent years earning trust…
Let's start with the headline nobody in Washington wants to print: marijuana is still illegal.…